Evidence Table 20Quality of studies using survey designs included for effect of testing on clinicians’ management or effect of testing and results on other outcomes


Reference List
  1. Heshka J, Palleschi C, Wilson B et al. Cognitive and Behavioural Effects of Genetic Testing for Thrombophilia. J Genet Couns 2008.
  2. Kaptein AA, van Korlaar IM, Cameron LD, Vossen CY, van der Meer FJ, Rosendaal FR. Using the common-sense model to predict risk perception and disease-related worry in individuals at increased risk for venous thrombosis. Health Psychol 2007; 26(6):807–12.
  3. Rodger MA, Carrier M, Keely E et al. The management of thrombophilia during pregnancy: a Canadian survey. J Obstet Gynaecol Can 2002; 24(12):946–52.
  4. Vossen CY, Walker ID, Svensson P et al. Recurrence rate after a first venous thrombosis in patients with familial thrombophilia. Arterioscler Thromb Vasc Biol 2005; 25(9):1992–7.
  5. Wahlander K, Eriksson H, Lundstrom T et al. Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism. Br J Haematol 2006; 133(1):68–77.
    Notes: CORPORATE NAME: THRIVE III Investigators
  6. Kearon C, Julian JA, Kovacs MJ et al. Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: Results from a randomized trial. Blood 2008.
  7. Ridker PM, Goldhaber SZ, Danielson E et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 2003; 348(15):1425–34.
    Notes: CORPORATE NAME: PREVENT Investigators
  8. Saukko PM, Ellard S, Richards SH, Shepherd MH, Campbell JL. Patients’ understanding of genetic susceptibility testing in mainstream medicine: qualitative study on thrombophilia. BMC Health Serv Res 2007; 7:82.
  9. Saukko PM, Richards SH, Shepherd MH, Campbell JL. Are genetic tests exceptional? Lessons from a qualitative study on thrombophilia. Soc Sci Med 2006; 63(7):1947–59.
  10. Bank I, Scavenius MP, Buller HR, Middeldorp S. Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice. Thromb Res 2004; 113(1):7–12.

From: Appendix G, Evidence Tables

Cover of Outcomes of Genetic Testing in Adults with a History of Venous Thromboembolism
Outcomes of Genetic Testing in Adults with a History of Venous Thromboembolism.
Evidence Reports/Technology Assessments, No. 180.
Segal JB, Brotman DJ, Emadi A, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.